Tag Archives: Clinical trial

Merck Shows Off Bevy of New Drugs

Image by Chemical Heritage Foundation via Flickr While Merck’s net profits might be a little low in the wake of the Schering-Plough merger, it’s pipeline—and future sales—are far from bleak. According to a new report from analyst firm Deutsche Bank, Merck has no less than 18 drugs in Phase III development, with three slated for […]
Posted in R&D, Strategy | Also tagged , , , , , | Leave a comment

InterMune Denied Approval for Lung Treatment

Image via Wikipedia Biotech firm InterMune took an ugly hit on Tuesday as news broke that its lung disease drug Esbriet (pirfenidone) will require additional clinical studies, and won’t be getting the seal of approval from FDA any time soon. The news caused InterMune’s stock to drop a staggering 78 percent, according to Reuters. Analysts […]
Posted in FDA, Strategy | Also tagged , , , , , | 1 Comment

A Critical Path to New TB Treatments

Image via Wikipedia FDA Commissioner Margaret Hamburg announced, on Thursday, a new joint initiative between industry, FDA, and non-profit organizations designed to fast-track modern combination treatments for tuberculosis. Where once it took more than two decades to create new therapies for TB, this collaboration is expected to produce working treatments in less than six years, […]
Posted in R&D | Also tagged , , , , , , | 2 Comments

Upcoming Webcast: The Visibility Solution

The Visibility Solution: Delivering an Accurate View of Clinical Operations Thursday, April 1, 2010 at 11:00 AM PT; 2:00 PM ET; 16:00 GMT This event focuses on our Clinical Trials solution with HighPoint Solutions and is designed to illustrate how pharma companies can reduce the risk and expense of the clinical trial process with better […]
Posted in Webcast | Also tagged , , , , , , | Leave a comment

JP Morgan Healthcare Conference Marked by Hesitant Optimism

Guest blog by Audrey S. Erbes, Principal, Erbes & Associates While last year’s meeting was dominated by the global economic crisis and its impact on the healthcare industry, this year’s presenters tried to give investors a glimmer of hope for better outcomes in the future. The fear that darkened moods of attendees in 2009 was […]
Posted in Events, Guest Blog | Also tagged , , , , , | 1 Comment
  • Categories

  • Meta